Asia continues to be a major growth market for MedTech companies as interest increases from companies to establish both manufacturing and innovation hubs in the region, especially in Singapore. 

As a major driving force for technology innovation in areas such as artificial intelligence and machine learning, many companies are looking to Singapore for its position as a leader on the cutting edge of the next wave of innovation in MedTech, given its vibrant biomedical sciences and advanced manufacturing sectors. 

Capturing insights shared at DeviceTalks Boston 2024, hear how global companies are leveraging Singapore’s access to clinical data, AI expertise, R&D partnerships and innovation talent to create new products and businesses for Asia and the world.